Faculty Disclosures
| Scott S. Zamvil, MD, PhD, FAAN |
Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion. |
| Crystal G. Wheeler |
No disclosure on file
|
| Olaf Stuve, MD, PhD, FAAN |
Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA. |
| Bernhard Hemmer, MD |
No disclosure on file
|
|
No disclosure on file
|
| Patrice LaLive, MD |
Dr. LaLive has nothing to disclose. |
| Anne Gocke |
No disclosure on file
|
| Petra Cravens, PhD |
No disclosure on file
|
| Wei Hu, MD, PhD |
No disclosure on file
|
| Jeffrey L. Elliott, MD |
No disclosure on file
|
| J. Scott Sloka, MD |
No disclosure on file
|
| Michael K. Racke, MD |
Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has stock in Quest Diagnostics. Dr. Racke has received intellectual property interests from a discovery or technology relating to health care. |
| Amy E. Lovett Racke, PhD |
No disclosure on file
|
| Luanne Metz, MD |
The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta. |
| Hans-Peter Hartung, MD, FAAN |
Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology. |
| Oliver Neuhaus, MD |
No disclosure on file
|
| Thomas Korn |
No disclosure on file
|
| Stefan Nessler, MD |
No disclosure on file
|
| Martin Weber, MD |
Dr. Weber has nothing to disclose. |
| Marie-Laure Santiago-Raber, PhD |
No disclosure on file
|
| Sima S. Zein, PhD |
No disclosure on file
|
| Patrick Vollmar |
No disclosure on file
|
| Christine Stadelmann-Nessler |
No disclosure on file
|
| Dorothea A. Buck, MD |
No disclosure on file
|
| John Dsurney, PhD, ABPP |
No disclosure on file
|
| Sarah E. Buckingham, MD |
No disclosure on file
|
| Bridgette J. Billioux, MD |
Dr. Billioux has nothing to disclose. |
| Shila Azodi, MD |
Dr. Azodi has nothing to disclose. |